A revenue cycle director sees the same DRG denial pattern every Monday morning. Nobody outside her hospital has ever named it to her.

Your hospital clients lose millions to DRG downgrades and clinical validation denials each year. Your firm finds the documentation gaps, builds the physician queries, and files the appeals that recover that revenue. Your pipeline, if you are like most firms in this space, comes from two places: conference relationships and the occasional desperate CFO who found you through a peer. Both have limits. Email Correspondence and Direct Mail reach the revenue cycle directors and CDI managers who do not yet know your name but live with the problem you solve.

The buyer is a revenue cycle director, not a C-suite dreamer

Hospital CFOs sign the engagement. They do not discover it. The person who feels the DRG downgrade first is the revenue cycle director, or sometimes the director of case management or clinical documentation improvement.

She sees the RAC audit results every Monday, knows which DRG shifts hit her facility's case mix index, and has a spreadsheet of denied claims by reason code where the clinical validation denials, the ones where the payer says the documented condition does not meet the definition of a secondary diagnosis, are the ones that make her stomach turn. Those are not coding errors. They are physician documentation failures that require a specific intervention she may not have in-house.

Your buyer has attended HFMA regionals, heard three vendors promise "automation" and deliver templates, and is skeptical of anyone who does not speak CMS-HCC or know the difference between a clinical validation denial and a coding denial. She is also overworked, under constant audit pressure, and managing a team that turns over every eighteen months.

Why referrals cap out in this vertical

The hospital revenue cycle community is tight. Directors move between systems and bring vendor relationships with them, so a single success at a flagship academic medical center can produce three more engagements through pure network effect.

This is how most firms built their book, and it is also why growth stalls: your referrers know directors in the same metro area and HFMA chapter, but not the director at a community hospital two states over whose sepsis denials just spiked because her prior vendor stopped operating, or the new director at a failing rural system with no vendor relationships yet.

Email Correspondence and Direct Mail do not require social proximity. They require only that the problem exists, the title is identifiable, and the message names the problem with enough precision to survive the recipient's first-glance filter. The correspondence builds a relationship that did not exist, which is the entire point.

The correspondence names her problem, not your service

ROI Wire writes letters and emails that read like they came from a senior appeal consultant who has seen this exact pattern before. A first line might read: "Your case mix index dropped 0.08 points last quarter, driven by CC/MCC capture failure on respiratory DRGs. The documentation supports the higher weight. The coding does not." This works because it describes the recipient's life, not the sender's offer, and the specificity signals the writer has done this work and knows this payer's denial language.

The body establishes credibility through mechanism, not credential: how the appeal is built, the targeted physician query, the literature review that supports the clinical relationship, the rebuttal to the payer's specific rationale. It never claims "proven results" or "industry-leading recovery rates." It demonstrates expertise by showing the work, then closes with a small, concrete ask, a 20-minute conversation to review five recent denials, or a request to send the firm's standard physician query template for a specific condition.

Hospital mailrooms are slow, which is an advantage here. A letter is opened, logged, and routed by hand, which means it is handled as physical matter in a way email is not, sits on a desk, and gets shown to a colleague with the question, "Do you know these people?" The letter does not ask for a meeting. It asks a specific question designed to be forwarded, such as whether the facility has seen the same pattern of AKI denials from Medicare Advantage plans.

Email Correspondence runs in sequences of four to six messages over eight to twelve weeks, each addressing a different facet of the denial problem, sepsis DRGs, AKI capture, malnutrition secondary diagnoses. The subject line names a specific payer, denial code, or regulatory deadline, since "revenue cycle solutions" dies in the filter but a subject naming the actual pattern gets opened because it might be from her own team, and the first paragraph contains no firm history or client count, only the pattern and the question.

Ready to grow your pipeline?

Share a few details and we'll follow up with exactly how this works for a firm like yours.

Leave blank

Name *

Firm / Company *

Email *

Phone

Send

A phone call, where it fits the account

We do not run a phone program for every account. Where one fits, it comes after the second Direct Mail piece or the third email, placed by a caller who has read the correspondence and opens with a reference to it: a letter sent on a specific date about a specific DRG pattern, and whether she had a chance to look at the trend data included.

The call determines whether the problem is current, whether she has authority to engage, and whether a brief conversation about five specific denials would be useful, running four to seven minutes if it connects.

What ROI Wire does not touch

DRG appeal firms handle protected health information. ROI Wire does not. The correspondence is built from publicly available data, payer denial trends reported in industry publications, and CMS audit focus area announcements. ROI Wire never requests, receives, or handles patient records, claims data, or PHI. The appeal work itself, the physician queries, the medical record review, the ALJ filings, remain entirely with the client, and this separation is maintained explicitly in every engagement letter.

Revenue share or retainer, depending on the firm's situation

Where the firm has capacity for new hospital clients and the appeal work is high-ticket, the engagement runs on revenue share: the firm covers list acquisition, printing, and postage, and ROI Wire designs the correspondence, manages the sequences, handles phone follow-up, and takes a share of revenue from engagements that originate through the pipeline, paying nothing beyond direct infrastructure cost until the pipeline produces signed clients.

Where the firm is building reputation in a new region or prefers predictable expense, a monthly retainer covers full design and execution, with the firm owning the pipeline and relationships. There is no standard price; the model depends on average engagement value, geographic target, and the complexity of the denial patterns addressed.

Who this does not work for

ROI Wire declines engagements with firms that cannot articulate their own appeal methodology. A firm that promises "we handle everything" without describing how it builds the physician query or structures the ALJ argument will not survive direct correspondence with a sophisticated revenue cycle director, who will ask specific questions the firm must be able to answer.

We also do not engage with firms that have unresolved regulatory actions or expect the correspondence to compensate for a weak appeal product. The pipeline produces conversations with qualified buyers; closing them requires a named principal willing to take the calls personally, a defined target more specific than "any hospital with sepsis denials," and patience, since a hospital engagement often runs six to nine months from first correspondence to signed contract.

This is not generic denials work

A denied claims recovery firm handles individual claim denials in volume, and its buyer is a billing manager focused on throughput. A DRG and clinical validation appeal firm handles complex cases where the payer has challenged the clinical basis of the diagnosis, requiring physician engagement and often administrative law proceedings, and its buyer is a revenue cycle director or VP who reports to the CFO on case mix index and net patient revenue.

The correspondence has to reflect this: fluency in the distinction between a coding error and a clinical validation failure, in the language of 42 CFR 405 for Medicare appeals, in the CMS guidance treating clinical validation as separate from coding validation. The director who receives it has to recognize a peer in the work, not a vendor in a related category.

The specificity that earns a reply

The correspondence succeeds when it names what the director already knows but has not voiced: a shift in RAC focus to a specific CC/MCC capture issue, the exact denial language a Medicare Advantage plan uses for a specific clinical validation category, an ALJ decision that reversed a similar denial. None of this is secret or proprietary. It is simply not assembled and delivered to the right person at the right time by someone who clearly understands its significance. That assembly and delivery is the work.